Ketamine shows promise for lifting depression in Parkinson's patients
NCT ID NCT04944017
Summary
This study tested whether repeated ketamine infusions could safely reduce depression in people with Parkinson's disease. Fifty-one participants with both conditions received either ketamine or a placebo infusion. Researchers also used brain scans on some participants to understand how ketamine might work to improve mood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale New Haven Hospital
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.